Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Lutgens · SciRah

Researcher profile · Semantic Scholar

M. Lutgens

Share profile

M. Lutgens — researcher profile on SciRah

h-index: 14
Works: 44
Citations: 1,058

Most-cited papers

Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease: An Updated Meta-analysis of Population-based Cohort Studies
M. Lutgens, M. V. van Oijen, G. van der Heijden, F. Vleggaar +2 more
2013Inflammatory Bowel Diseases514 citations
Semantic Scholar
Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
Anouk M. Wijnands, M. D. de Jong, M. Lutgens, F. Hoentjen +2 more
2020Gastroenterology201 citations Open access
Semantic Scholar
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
L. Derikx, M. Lantinga, D. D. de Jong, W. V. van Dop +21 more
2020Journal of Crohn's & Colitis65 citations Open access
Semantic Scholar
Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Anouk M. Wijnands, R. Mahmoud, M. Lutgens, B. Oldenburg
2021European journal of internal medicine41 citations Open access
Semantic Scholar
A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
M. Lutgens, S. Vermeire, M. V. van Oijen, F. Vleggaar +4 more
2015Clinical Gastroenterology and Hepatology41 citations Open access
Semantic Scholar
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
S. Mahmmod, J. Schultheiss, A. V. van Bodegraven, G. Dijkstra +9 more
2021Inflammatory Bowel Diseases23 citations Open access
Semantic Scholar
Risk Factors for Rectal Stump Cancer in Inflammatory Bowel Disease
M. Lutgens, M. V. van Oijen, F. Vleggaar, P. Siersema +2 more
2012Diseases of the Colon & Rectum21 citations
Semantic Scholar
A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines.
M. Lutgens, M. V. van Oijen, E. Mooiweer, M. E. van der Valk +3 more
2014Gastrointestinal Endoscopy20 citations
Semantic Scholar
Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series.
E. Mooiweer, J. Baars, M. Lutgens, F. Vleggaar +5 more
2012Journal of Crohn's & Colitis17 citations Open access
Semantic Scholar
Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease.
Anouk M. Wijnands, Bas B. L. Penning de Vries, M. Lutgens, Z. Bakhshi +15 more
2024Clinical Gastroenterology and Hepatology15 citations Open access
Semantic Scholar
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease
M. M. van de Meeberg, H. Fidder, B. Oldenburg, J. Sundaresan +14 more
2023Alimentary Pharmacology and Therapeutics15 citations Open access
Semantic Scholar
Complete endoscopic healing is associated with a lower relapse risk after anti-TNF withdrawal in inflammatory bowel disease.
R. Mahmoud, E. Savelkoul, W. Mares, R. Goetgebuer +17 more
2022Clinical Gastroenterology and Hepatology14 citations Open access
Semantic Scholar
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
F. Crouwel, M. Simsek, M. D. de Boer, C. Mulder +28 more
2022Journal of Crohn's & Colitis14 citations Open access
Semantic Scholar
Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based report.
M. Lutgens, M. Meijer, B. Peeters, Marie-Louise N. F. Poulsen +4 more
2008Primary Care Diabetes14 citations Open access
Semantic Scholar
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
R. V. van Linschoten, F. Jansen, R. Pauwels, L. Smits +24 more
2023The Lancet Gastroenterology and Hepatology13 citations Open access
Semantic Scholar
194 A Comprehensive Meta-Analysis of the Risk of Colorectal Cancer in Ulcerative Colitis and Crohn's Disease
M. Lutgens, G. van der Heijden, F. Vleggaar, B. Oldenburg
20088 citations Open access
Semantic Scholar
Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment
Anouk M. Wijnands, Maarten Te Groen, Y. Peters, A. Kaptein +3 more
2021Inflammatory Bowel Diseases6 citations Open access
Semantic Scholar
P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar
S. Mahmmod, J. Schultheiss, A. Tan, M. Lutgens +7 more
20203 citations
Semantic Scholar
Vulvar and vaginal neoplasia in women with inflammatory bowel disease.
M. Rouvroye, G. Tack, C. Mom, B. Lissenberg-Witte +33 more
2019Digestive and Liver Disease3 citations
Semantic Scholar
Risk Factors for Advanced Neoplasia of the Rectal Stump in IBD Patients
M. Lutgens, P. Siersema, F. Vleggaar, M. Broekman +8 more
20113 citations Open access
Semantic Scholar
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
F. Jansen, R. V. van Linschoten, W. Kievit, L. Smits +23 more
2023Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients
M. Pierik, A. E. van der Meulen, K. van der Linde, M. Lutgens +8 more
2021Crohn's & Colitis 3602 citations Open access
Semantic Scholar
Different Risk Factors for Colitis Associated Colorectal Cancer in Ulcerative Colitis and Crohn's Disease
M. Lutgens, P. Siersema, F. Vleggaar, M. Broekman +8 more
20112 citations Open access
Semantic Scholar
P742 The efficacy of comprehensive multivitamin and mineral supplement to treat symptoms of fatigue in patients with Inflammatory Bowel Disease in remission with immunomodulators and or biological agents
R. Laheij, D. Bierens-Peters, K. Bruin, M. Lutgens +2 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
R. V. van Linschoten, F. Jansen, R. Pauwels, L. Smits +24 more
2024Digestive Diseases and Sciences1 citations Open access
Semantic Scholar
The Efficacy of an Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in Patients With Inflammatory Bowel Disease in Remission With Immunomodulators and/or Biological Agents: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Robin L. H. Laheij, Y. V. van Knippenberg, A. L. Heil, B. Mannaerts +5 more
2023Inflammatory Bowel Diseases1 citations
Semantic Scholar
197 More Right-Sided IBD-Associated Colorectal Cancer in Patients with Primary Sclerosing Cholangitis
M. Claessen, M. Lutgens, H. V. van Buuren, B. Oldenburg +3 more
20081 citations
Semantic Scholar
199 Colonoscopic Surveillance in Inflammatory Bowel Disease Improves Survival After Colorectal Cancer Diagnosis
M. Lutgens, B. Oldenburg, P. Siersema, F. Vleggaar
20081 citations
Semantic Scholar
O10 Screening And Surveillance For Colorectal Carcinoma in Patients With Ulcerative Colitis and Crohn's Disease: Are Current Surveillance Guidelines Adequate? Interim Analysis of a Retrospective Multi-Center Descriptive Study
M. Lutgens, F. Vleggaar, B. Oldenburg, M. Schipper +5 more
20071 citations Open access
Semantic Scholar
P0828 Crohn’s disease patients respond better to vedolizumab if biologic-naïve
S. Dijkstra, J. Schultheiss, W. Mares, B. Jharap +5 more
2026Journal of Crohn's & Colitis0 citations
Semantic Scholar
Su1849: LONG-TERM OUTCOMES OF EXTENDED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVAL FOR PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: 3-YEAR FOLLOW-UP OF THE RANDOMIZED CONTROLLED LADI TRIAL
L. V. van Lierop, Monique J. C. Devillers, R. V. van Linschoten, F. Jansen +23 more
2025Gastroenterology0 citations
Semantic Scholar
P0860 Long-term outcomes of extended versus conventional adalimumab dose interval for patients with Crohn’s disease in stable remission: 3-year follow-up of the randomized controlled LADI trial
M. Devillers, L. V. van Lierop, R. V. van Linschoten, F. Jansen +23 more
2025Journal of Crohn's & Colitis0 citations
Semantic Scholar
Sa1823 DEVELOPMENT AND INTERNAL-EXTERNAL VALIDATION OF A DYNAMIC MULTIVARIABLE PREDICTION MODEL FOR ADVANCED COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Anouk M. Wijnands, B. D. de Vries, M. Lutgens, Z. Bakhshi +15 more
2024Gastroenterology0 citations
Semantic Scholar
P816 The efficacy of an over the counter multivitamin and mineral supplement to prevent opportunistic infections in patients with inflammatory bowel disease in remission
R. Laheij, Y. V. van Knippenberg, A. Heil, B. Mannaerts +4 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial
R. V. van Linschoten, F. Jansen, R. Pauwels, L. Smits +24 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
P384 A higher red blood cell methotrexate polyglutamate 3 concentration is associated with methotrexate drug-survival in patients with Crohn’s Disease: first results of a prospective cohort
M. M. van de Meeberg, H. Fidder, J. Sundaresan, E. Struys +12 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
DOP70 Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective study
R. Mahmoud, E. Savelkoul, W. Mares, R. Goetgebuer +14 more
2022Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
Mo1539: ANTI-TNF WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ENDOSCOPIC REMISSION: A PROSPECTIVE STUDY
R. Mahmoud, E. Savelkoul, W. Mares, R. Goetgebuer +15 more
2022Gastroenterology0 citations
Semantic Scholar
Tu1498: WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY
E. Savelkoul, R. Mahmoud, D. D. de Jong, W. V. van Dop +16 more
2022Gastroenterology0 citations
Semantic Scholar
P309 Withdrawal of thiopurines in Inflammatory Bowel Disease patients in stable remission: a prospective, multicentre cohort study
E. Savelkoul, R. Mahmoud, D. D. de Jong, W. V. van Dop +16 more
2022Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
P155 Bowel preparation is valued more than colorectal cancer risk and interval by patients in colitis-associated colorectal cancer surveillance: a discrete choice experiment
A. Wijnands, M. Groen, Y. Peters, A. Kaptein +3 more
20210 citations Open access
Semantic Scholar
T1304 Colorectal Cancer in Inflammatory Bowel Disease: A Comparison Between Large Cohorts From Referral Centers and General Hospitals
E. Mooiweer, J. Baars, M. Lutgens, P. Siersema +3 more
20100 citations Open access
Semantic Scholar
Screening and surveillance for colorectal carcinoma in patients with ulcerative colitis and Crohn's disease: are current surveillance guidelines adequate? Interim analysis of a retrospective multicentre descriptive study
M. Lutgens, F. Vleggaar, B. Oldenburg, M. Schipper +5 more
20080 citations
Semantic Scholar
Surveillance for colorectal carcinoma in patients with inflammatory bowel disease: are AGA and BSG guidelines adequate?
M. Lutgens, F. Vleggaar, B. Oldenburg, M. Samsom
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Oldenburg×34
Invite
B. Oldenburg — researcher profile on SciRah
F. Hoentjen×18
Invite
F. Hoentjen — researcher profile on SciRah
F. Vleggaar×13
Invite
F. Vleggaar — researcher profile on SciRah
D. D. de Jong×13
Invite
D. D. de Jong — researcher profile on SciRah

A. V. van Bodegraven

×11

Invite

A. V. van Bodegraven — researcher profile on SciRah

Invite

N. Mahmmod — researcher profile on SciRah

Invite

P. Boekema — researcher profile on SciRah

Invite

P. Siersema — researcher profile on SciRah

Invite

J. Jansen — researcher profile on SciRah

N. D. de Boer×9

Invite

N. D. de Boer — researcher profile on SciRah

Invite

A. Bodelier — researcher profile on SciRah

Invite

B. Jharap — researcher profile on SciRah